Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for Myeloproliferative Neoplasms
NCT05123365Phase 2Recruiting
- Sponsor
- University of California, Irvine
- Start
- Jan 2022
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in essential thrombocythemia (ET), polycythemia vera (PV), myelofibrosis (MF), sponsored by University of California, Irvine. Started Jan 2022; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
essential thrombocythemia (ET)polycythemia vera (PV)myelofibrosis (MF)
Beyond the preview
Go deeper on NCT05123365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05123365.